Research Article
Predictive Value of Heart-Type Fatty Acid-Binding Protein for Mortality Risk in Critically Ill Patients
Table 1
Comparison of patient baseline data.
| | Nonsurvivor group () | Survivor group () | |
| | Gender (male/female) | 33/13 | 62/42 | 0.107 | | Age (years) | | | 0.001 | | Underlying disease | | | | | Diabetes (yes/no) | 17/29 | 42/62 | 0.721 | | Hypertension (yes/no) | 14/32 | 31/73 | 0.938 | | Coronary heart disease (yes/no) | 16/30 | 28/76 | 0.338 | | Main diagnosis | | | 0.577 | | Respiratory system | 23 (34.0%) | 45 (66.0%) | | | Cardiovascular system diseases | 10 (24.4%) | 31 (75.6%) | | | Other | 13 (31.7%) | 28 (68.3%) | | | APACHE II | | | 0.001 | | SOFA | 5.0 (3.8, 7.3) | 2.0 (1.0, 4.0) | 0.001 | | GCS | 13.5 (11.8, 15.0) | 15.0 (15.0, 15.0) | 0.001 | | WBC (109/l) | | | 0.491 | | CRP (mg/l) | | | 0.717 | | HB (g/l) | | | 0.925 | | PLT (109/l) | | | 0.656 | | Scr (umol/l) | 99.7 (68.6, 224.2) | 74.7 (55.9, 94.8) | 0.001 | | LAC (mmol/l) | 2.3 (1.4, 3.4) | 1.2 (0.8, 2.0) | 0.001 | | PCT (ng/ml) | 0.14 (0.05, 1.33) | 0.08 (0.02, 0.37) | 0.051 | | H-FABP (ng/ml) | 6.9 (3.9, 33.0) | 3.6 (2.0, 6.6) | 0.001 | | cTNI (ng/ml) | 0.06 (0.04, 0.59) | 0.05 (0.03, 0.27) | 0.139 | | IL-6 (pg/ml) | 51.6 (14.7, 139.3) | 19.4 (5.3, 64.7) | 0.001 | | D-dimer (mg/l) | 1.9 (1.00, 11.8) | 0.9 (0.4, 3.7) | 0.001 |
|
|
aAPACHE II: acute physiology and chronic health evaluation II; SOFA: sequential organ failure assessment score; GCS: Glasgow coma scale; H-FABP: heart-type fatty acid-binding protein; PCT: procalcitonin; cTNI: cardiac troponin I; IL-6: interleukin 6; LAC: lactate; Scr: serum creatinine; CRP: C-reactive protein; HB: hemoglobin. The differences were statistically significant when . |
